ScholarIQanswers from OpenAlex & ORCID
Karel Pavelká
ResearcherPublications, citations & collaboration network
Karel Pavelká is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Karel Pavelká have?
ScholarIQindexed works
Karel Pavelká has 852 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Karel Pavelká have?
ScholarIQcitation count
Karel Pavelká has 44,203 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Karel Pavelká?
ScholarIQh-index
Karel Pavelká has an h-index of 76 in OpenAlex.
What is the i10-index of Karel Pavelká?
ScholarIQi10-index
Karel Pavelká has an i10-index of 257 in OpenAlex.
What is the ORCID of Karel Pavelká?
ScholarIQorcid
The ORCID for Karel Pavelká is on the source record.
What is the OpenAlex record for Karel Pavelká?
ScholarIQopenalex
The OpenAlex for Karel Pavelká is on the source record.
What are the most-cited papers on Karel Pavelká?
ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley Cohen, Karel Pavelká, Ronald van Vollenhoven, John T. Sharp, John L. Perez, G Spencer-Green
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Simone Gorter, Rachel Knevel, J. Nam, Monika Schoels, Daniel Aletaha, Maya H Buch, Laure Gossec, T. Huizinga, J. W. J. Bijlsma, Gerd R Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan J. Gómez‐Reino, Marios Kouloumas, Tore K Kvien, E. Martín‐Mola, Iain B. McInnes, Karel Pavelká, Piet L. C. M. van Riel, M. Scholte, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin Winthrop, John B. Wong, A. Zink, Désirée van der Heijde
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
Linda Fernandes, Kåre Birger Hagen, J. W. J. Bijlsma, Øyvor Andreassen, P. Christensen, Philip G. Conaghan, Michael Doherty, Rinie Geenen, Alison Hammond, Ingvild Kjeken, Stefan Lohmander, Hans Lund, Christian Mallen, Tiziana Nava, Susan Oliver, Karel Pavelká, I. Pitsillidou, José António Pereira da Silva, Jenny de la Torre-Aboki, Gustavo Zanoli, T. P. M. Vliet Vlieland
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Joseph M. Braun, Rosaline van den Berg, Xenofon Baraliakos, Heinrich Boehm, R Burgos-Vargas, Eduardo Collantes‐Estévez, Hanne Dagfinrud, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Pál Géher, M. Hammoudeh, RD Inman, Merryn Jongkees, MA Khan, Uta Kiltz, Tore K Kvien, Marjatta Leirisalo‐Repo, Walter P. Maksymowych, Ignazio Olivieri, Karel Pavelká, J. Sieper, Ewa Stanisławska‐Biernat, Daniel Wendling, Salih Özgöçmen, C van Drogen, Barend J. van Royen, D. van der Heijde